PublicWire | Emerging Market Stock News
  •  Home
  • Technology
  • Medical
  • Energy
  • Cannabis
  • Finance
  • Retail
  • General
  • Podcast
  • Videos
  • Services
  •  Home
  • Technology
  • Medical
  • Energy
  • Cannabis
  • Finance
  • Retail
  • General
  • Podcast
  • Videos
  • Services
No Result
View All Result
PublicWire
No Result
View All Result

Home » Cannabis » Medical Marijuana, Inc. Announces Largest Revenue Quarter and Sales Month in Company History, 269% Revenue Increase From Q2 2016

Medical Marijuana, Inc. Announces Largest Revenue Quarter and Sales Month in Company History, 269% Revenue Increase From Q2 2016

by PublicWire
April 26, 2019
in Cannabis
Reading Time: 3 mins read
0

Medical Marijuana, Inc. Wholly Owned Subsidiary Kannaway Has Largest Sales Month in June Since Company Was Founded

PR Newswire

SAN DIEGO, July 11, 2017, MJNA

SAN DIEGO, July 11, 2017 /PRNewswire/ – Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the second quarter of 2017 generated the largest revenue quarter in the Company’s history. Additionally, the Company celebrated the largest-ever single month of revenue in June 2017 as well as the largest sales month and quarter for wholly owned subsidiary Kannaway.

The Company saw a gross revenue increase from $1,660,633 in Q2 2016 to $6,131,415 in Q2 2017, a quarter-over-quarter increase of 269% making it the largest quarter in the Company’s history. The Company also saw year-to-date and year-over-year revenue increase from $3,177,103 to $9,651,088 an increase of 203%.

“As a well-known Company of Firsts, we are encouraged to see the Company achieve a new milestone – hitting its highest revenue mark ever in this last financial quarter,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “We continue to work closely with our portfolio of companies to ensure their success, and look forward to breaking new records as we continue to expand our footprint in new markets.”

“We are confident that Kannaway® is on a trajectory that continues to exceed expectations,” said Kannaway® CEO Blake Schroeder. “We are proud to be a part of the Medical Marijuana, Inc. family, which actively supports efforts to increase access to cannabidiol (CBD) products worldwide.”

About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.

To see Medical Marijuana, Inc.’s video statement, click here.

Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.

FORWARD-LOOKING DISCLAIMER AND DISCLOSURES

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

The statements in this press release have not been evaluated by the Food and Drug Administration (FDA) and are not intended to diagnose, treat or cure any disease.  The Company does not sell or distribute any products that are in violation of the United States Controlled Substances Act. The Company does sell and distribute hemp-based products.

 

Tags: cannabisHEMPMedical Marijuana IncMJNArevenuesales
Previous Post

KonaRed Corporation Announces Continued Record Sales Increases for Q2

Next Post

With Over $2.1 Million in Total Revenues, April and May Figures Top First Quarter Results as PotNetwork Continues Cultivating for Growing Returns

PublicWire

At PublicWire, we know the vast majority of all investors conduct their due diligence and get their news online in a variety of ways including email, social media, financial websites, text messages, RSS feeds and audio/video podcasts. PublicWire’s financial communications program is uniquely positioned to reach these investors throughout the U.S. and Canada as well as on a global scale.

Related Posts

Photo by GRAS GRÜN on Unsplash
Cannabis

Zenabis returned $1.9 million worth of pot to Sundial over bad quality and visible molds

August 22, 2019
0
Photo by Rick Proctor on Unsplash
Cannabis

Tilray to start exporting medicinal pot to Germany

August 21, 2019
0
Photo by Esteban Lopez on Unsplash
Cannabis

CannTrust stocks fell another 5% after weed distributor returned millions worth of pot

August 20, 2019
0
Photo by Roberto Valdivia on Unsplash
Cannabis

Cannabis stocks fell as possible recession brews

August 14, 2019
0
Cannabis

Aurora Cannabis hovers trade flat amid strong market

August 13, 2019
0
Photo by Get Budding on Unsplash
Cannabis

Health inspectors flagged CannTrust’s non-compliance again, sending stocks down by 26%

August 12, 2019
0
Next Post
PotNetwork Holdings

With Over $2.1 Million in Total Revenues, April and May Figures Top First Quarter Results as PotNetwork Continues Cultivating for Growing Returns

Please login to join discussion

Subscribe To Our Newsletter

Loading
Ad
PublicWire | Emerging Market Stock News 24/7 | Investor Relations US Stock Market

© Copyright 2022 publicwire.com

Navigate Site

  • About
  • Contact Us
  • Disclaimer
  • Watch LIVE
  • Privacy Policy
  • Terms and Services
  • Contributors

Follow Us

No Result
View All Result
  • LIVE Investor News Channel
  • Cannabis
  • Energy
  • Finance
  • General
  • Medical
  • Podcasts
  • Retail
  • Technology
  • Videos

© Copyright 2022 publicwire.com

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.